After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Catalent Inc. is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Catalent Inc. is $11.02B. A total of 0.67 million shares were traded on the day, compared to an average of 1.81M shares.
In the most recent transaction, McErlane David sold 1,994 shares of CTLT for 59.97 per share on Sep 26 ’24. After the transaction, the Group President, Biologics now owns 36,304 company shares. In a previous transaction on Sep 26 ’24, McErlane David bought 2,168 shares at 59.98 per share.
Among the insiders who sold shares, Hopson Ricky disposed of 662 shares on Aug 02 ’24 at a per-share price of $59.56. This resulted in the Pres. BioProduct Delivery, CoS holding 29,974 shares of CTLT after the transaction. In another insider transaction, Gunther Scott sold 666 shares at $59.55 per share on Aug 02 ’24. Company shares held by the SVP, Quality & Reg. Affairs now total 39,635.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CTLT has a high of $61.20 and a low of $31.80.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CTLT’s latest balance sheet shows that the firm has $538.00M in Cash & Short Term Investments as of fiscal 2022. There were $4.22B in debt and $1.10B in liabilities at the time. Its Book Value Per Share was $19.91, while its Total Shareholder’s Equity was $4.78B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTLT is Buy with a score of 3.20.
